David A. Irvine
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Hematology 11
- Chronic Myeloid Leukemia Treatments 9
- Oncology 17
- CAR-T cell therapy research 15
- Co-authors
- Mhairi Copland (10 shared papers)David Gunnell (1 shared paper)Charlotte Aull Davies (1 shared paper)Lauren Anne Wise (1 shared paper)Richard Michael Martin (1 shared paper)Tessa L. Holyoake (7 shared papers)Michael L. Bagshaw (2 shared papers)Richard J. G. Rycroft (3 shared papers)
- Journals
- Blood (8 papers)British Journal of Haematology (2 papers)Journal of Clinical Oncology (2 papers)Hematological Oncology (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
David A. Irvine
51 papers receiving 1.5k citations
David A. Irvine's Hit Papers
Peers
Comparison fields: 5 of 116
- Hematology 374
- Oncology 438
- Genetics 153
- Dermatology 82
- Small Animals 59
Countries citing papers authored by David A. Irvine
This map shows the geographic impact of David A. Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Irvine more than expected).
Fields of papers citing papers by David A. Irvine
This network shows the impact of papers produced by David A. Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Irvine. The network helps show where David A. Irvine may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Irvine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 166 | |
| 2 | 2013 | 122 | |
| 3 | 2012 | 117 | |
| 4 | Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 Hit paper breakdown → | 2024 | 117 |
| 5 | 2021 | 108 | |
| 6 | 2023 | 107 | |
| 7 | 2003 | 81 | |
| 8 | 2016 | 64 | |
| 9 | 1998 | 63 | |
| 10 | 2023 | 62 | |
| 11 | British Airways flightdeck mortality study, 1950-1992. | 1999 | 60 |
| 12 | 2020 | 56 | |
| 13 | 1989 | 50 | |
| 14 | 2010 | 41 | |
| 15 | 1996 | 37 | |
| 16 | The mortality of British Airways pilots, 1966-1989: a proportional mortality study. | 1992 | 35 |
| 17 | 2005 | 31 | |
| 18 | 2012 | 27 | |
| 19 | 2009 | 23 | |
| 20 | 2022 | 22 |
About David A. Irvine
David A. Irvine is a scholar working on Hematology, Oncology, Genetics, Rheumatology and Health, Toxicology and Mutagenesis, having authored 53 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Eosinophilic Disorders and Syndromes (5 papers), Hedgehog Signaling Pathway Studies (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Air Quality and Health Impacts (3 papers) and Pesticide Exposure and Toxicity (3 papers). The work is most often cited by research in Hematology (374 citations), Oncology (438 citations), Genetics (153 citations), Dermatology (82 citations) and Small Animals (59 citations). David A. Irvine has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Mhairi Copland, David Gunnell, Charlotte Aull Davies, Lauren Anne Wise, Richard Michael Martin, Tessa L. Holyoake, Michael L. Bagshaw, Richard J. G. Rycroft, Ravi Bhatia and D.W. PRYCE. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Hematological Oncology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.